Published: 2020-08-25

Tryptase plays a role in solid tumor angiogenesis and cell proliferation

Anisha Mathew, Manisha Naithani, Amit Sehrawat, Deepak Sundriyal, Pulturu Venkata Shilpa, Uttam Kumar Nath


Tryptase, a serine protease released during mast cell degranulation has been associated with anaphylactic reactions and inflammations. In recent studies on solid tumor proliferation, it has been seen that tryptase has a role in tumor angiogenesis and tumor cell proliferation. This also makes tryptase a potential therapeutic target. Many anti-tryptase agents have shown to decrease tumor angiogenesis and proliferation. Authors have thus reviewed various articles which have done extensive studies on the role of tryptase as an important factor in tumor proliferation and angiogenesis.


Solid tumor, Tryptase, Tumor angiogenesis

Full Text:



Trivedi NN, Caughey GH. Handbook of proteolytic enzymes. 3rd edition. Chapter: Human α-, β- and δ-tryptase. Elseiver’s. 2013;2683-93.

Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol. 1987;126(4):1290-4.

Immuno Cap Tryptase (Product Insert). Uppsala Sweden; 2007.

Human TPSABI/mast cell serum tryptase kit. User manual. Lifespan Biosciences. North America; 2009.

Foster B, Schwartz B. L, Devouassoux G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase- expressing peripheral blood cells as basophils. J Allergy Clin Immunol. 2002;109:287-93.

Sperr WR, Jordan JH, Fiegl M, Escribano L, Bellas C, Dirhofer S, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128:136-44.

Brahim SJ, Min HK, Fukuoka Y, Xia HZ, Schwatz BL. Expression of α-tryptase and β-tryptase by human basophils. J Allergy Clin Immunol. 2004;113(6):1086-92.

Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125:5591-6.

Kelta E, Ashall F, Abubeker A. Assessment of serum tryptase activity among acute and chronic myeloid leukemia patients visiting hematology-oncology clinic at tikuranbessa specialized hospital and comparision with healthy ontrols. Cancer Res J. 2018;6(1):26-37.

Garcia MG, Faderal S, O’BS, Cortes J, Talpa M, Kantarjian MH. CML: a review and update therapeutic strategies. Am Cancer Society. 2003;98(3):437-57.

Qian N, Li X, Wang X, Wu C, Yin L, Zhi X. Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation. Oncol Letters. 2018;16(2):1513-20.

Marech I, Ammendola M, Leporini C, Patruno R, Luposella M, Zizzo, et al. C-kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients. Oncotarget. 2017;9(8):7918.

Marech I, Ammendola M, Sacco R, Capriuolo GS, Patruno R, Rubini R, et al. Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance. BMC Cancer. 2014;14(1):534.

Xiang M, Gu Y, Lu H, Chen S, Yin L. Mast cell tryptase promotes breast cancer migration and invasion. Oncol Reports. 2010;23(3):615-19.

Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer. 1997;72(3):385-8.

Ribatti D, Finato N, Crivellato E, Guidolin D, Longo V, Mangieri D, et al. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathol. 2007;51(6):837-42.

Ranieri G, Ammendola M, Patruno R, Celano G, Zito FA, Montemurro S, et al. Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol. 2009;35(1):115-20.

Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, et al. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res. 2010;16(8):2257-65.

Guo X, Zhai L, Xue R, Shi J, Zeng Q, Gao C. Mast cell tryptase contributes to pancreatic cancer growth through promoting angiogenesis via activation of angiopoietin-1. Int J Mol Sci. 2016;17(6):834-45.

Ammendola M, Gadaleta CD, Frampton AE, Piardi T, Memeo R, Zuccalà V, et al. The density of mast cells c-Kit+and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. Oncotarget. 2017;8(41):463-71.

Ammendola M, Sacco R, Donato G, Zuccalà V, Russo E, Luposella M, et al. Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncol. 2013;85(2):111-6.

Malfettone A, Silvestris N, Saponaro C, Ranieri G, Russo A, Caruso S, et al. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression. J Cellular Mol Med. 2013;17(8):1025-37.

Ammendola M, Sacco R, Sammarco G, Donato G, Montemurro S, Ruggieri E, et al. Correlation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: possible biological-clinical significance. PLoS ONE. 2014;9(6):e99512.

Suzuki S, Ichikawa Y, Nakagawa K, Kumamoto T, Mori R, Matsuyama R, et al. High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases. BMC Cancer. 2015;15(1):2-8.

Sammarco G, Gadaleta CD, Zuccalà V, Albayrak E, Patruno R, Milella P, et al. Tumor-associated macrophages and mast cells positive to tryptase are correlated with angiogenesis in surgically-treated gastric cancer patients. Int J Mol Sci. 2018;19(4):1176-90.

Ribatti D, Finato N, Crivellato E, Marzullo A, Mangieri D, Nico B, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol. 2005;193(6):1961-5.

Ammendola M, Leporini C, Marech I, Gadaleta CD, Scognamillo G, Sacco R, et al. Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy. BioMed research international. 2014;Article ID 154702.

Yoon WH, Jung YJ, Kim TD, Li G, Park BJ, Kim JY, et al. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Clin Cancer Res. 2004;10(13):4517-26.

Brandi G, Tavolari S, De Rosa F, Di Girolamo S, Agostini V, Barbera MA, et al. Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations. PLoS One. 2012;7(7):e41347.

Uchima Y, Sawada T, Nishihara T, Umekawa T, Ohira M, Ishikawa T, et al. Identification of a trypsinogen activity stimulating factor produced by pancreatic cancer cells: its role in tumor invasion and metastasis. Int J Mol Med. 2003;12(6):871-8.

Aoyama T, Ino Y, Ozekietal M. Pharmacological studies of FUT-175, Nafamstat Mesylate. I. Inhibition of protease activity in in vitro and in vivo experiments. Japanese J Pharmacol. 1984;35(3):203-27.

Tajima H, Ohta T, Elnemr A, Yasui T, Kitagawa H, Fushida S, et al. Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA. Int J Cancer. 2001;94(5):699-704.

Hiroi M, Onda M, Uchida E, Aimoto T. Anti-tumor effect of N-[3, 4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer. J Nippon Med School. 2002;69(3):224-34.

Subramaniam V, Chakrabarti R, Prud'homme GJ, Jothy S. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer. Anti-cancer Drugs. 2010;21(4):351-61.